Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing a Non-Surgical Mouse Model of Laryngopharyngeal Reflux Disease: Acid-Induced Epithelial Disruption and Protective Role of N-Acetylcysteine.

Cells·2026
Same author

First experimental proof of PET imaging based on multi-anode MCP-PMTs with Cherenkov radiator-integrated window.

Physics in medicine and biology·2025
Same author

The new composition of circulating microvesicles: optimized protocols and reassessment of their characteristics and physiological functions.

Life medicine·2025
Same author

Establishment of a prognostic model based on ER stress-related cell death genes and proposing a novel combination therapy in acute myeloid leukemia.

Journal of translational medicine·2025
Same author

WBSCR16 is essential for mitochondrial 16S rRNA processing in mammals.

Nucleic acids research·2025
Same author

Unveiling Biomarkers in Head and Neck Squamous Cell Carcinoma through Bioinformatics: The Role of <i>SPP1</i> and <i>KRT78</i>.

International journal of molecular sciences·2024

Related Experiment Video

Updated: May 31, 2026

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
07:26

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis

Published on: April 1, 2022

Bone morphogenetic protein-1 processes insulin-like growth factor-binding protein 3.

Byoungjae Kim1, Guorui Huang1, Wen-Bin Ho2

  • 1Department of Cell and Regenerative Biology, and the Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin 53706 and.

The Journal of Biological Chemistry
|June 24, 2011
PubMed
Summary

Bone morphogenetic protein-1 (BMP1) cleaves insulin-like growth factor-binding protein 3 (IGFBP3), altering its ability to bind IGF-I and affect cell signaling. This cleavage impacts growth factor activity and extracellular matrix regulation.

More Related Videos

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Related Experiment Videos

Last Updated: May 31, 2026

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
07:26

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis

Published on: April 1, 2022

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Bone morphogenetic protein-1 (BMP1)-like metalloproteinases are crucial for extracellular matrix formation and growth factor activation.
  • Insulin-like growth factor-binding proteins (IGFBPs), particularly IGFBP3, regulate insulin-like growth factor (IGF) effects on growth, development, and metabolism.
  • IGFBP3 undergoes proteolytic processing, influencing its biological activity.

Purpose of the Study:

  • To investigate the specific cleavage of IGFBP3 by BMP1.
  • To determine the functional consequences of BMP1-mediated IGFBP3 cleavage on IGF-I binding and cell signaling.
  • To demonstrate the in vivo relevance of BMP1-related proteinases in processing IGFBP3.

Main Methods:

  • In vitro cleavage assays using human and mouse IGFBP3 with BMP1.
  • Assessment of IGF-I binding and IGF-I-induced cell signaling in cleaved versus uncleaved IGFBP3.
  • Analysis of IGFBP3 processing in wild-type and Bmp1/Tll1 double knockout mouse embryo fibroblasts (MEFs).
  • In vivo studies in zebrafish embryos involving Bmp1a overexpression and Igfbp3 phenotypes.

Main Results:

  • BMP1 cleaves human and mouse IGFBP3 at a conserved site, significantly reducing its ability to bind IGF-I and inhibit IGF-I-induced signaling.
  • Cleaved IGFBP3 exhibits enhanced IGF-I-independent inhibition of FGF-induced proliferation and promotes Smad phosphorylation.
  • MEFs deficient in BMP1 and mammalian Tolloid-like 1 (mTLL1) show reduced IGFBP3 processing, confirming the role of endogenous BMP1-related proteinases.
  • Overexpression of Bmp1a in zebrafish embryos reverses Igfbp3-induced phenotypes, supporting in vivo cleavage of IGFBP3.

Conclusions:

  • BMP1-mediated cleavage of IGFBP3 alters its interaction with IGF-I and modulates downstream signaling pathways.
  • The proteolytic processing of IGFBP3 by BMP1-like proteinases is biologically relevant in vivo, affecting cellular processes.
  • This study elucidates a novel regulatory mechanism for IGFBP3 function by BMP1-like metalloproteinases.